Managing Health Effects of Beryllium Exposure (2008)

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendix A Biographic Information on the Committee on Beryllium Alloy Exposures Charles H. Hobbs (Chair) is director of the Toxicology Division of the Love- lace Respiratory Research Institute and vice-president of the Lovelace Biomedi- cal and Environmental Research Institute. He also holds an appointment as clinical professor in the College of Pharmacy of the University of New Mexico. His research interests are in the long-term biologic effects of inhaled materials and the mechanisms by which they occur. His experience covers inhaled nuclear and chemical toxicants and infectious diseases and has ranged from physical and chemical characterization of airborne toxicants to in vitro mechanistic and toxi- cologic studies of dose-response relationships in laboratory animals. Dr. Hobbs is a national associate of the National Academies and has served on several committees of the National Research Council, including service as chair of the Committee on Animal Models for Testing Interventions Against Aerosolized Bioterrorism Agents and of the Committee on Submarine Escape Action Levels. He received his DVM from Colorado State University. Patrick N. Breysse is a professor in the Department of Environmental Health Sciences and director of the Division of Environmental Health Engineering of the Johns Hopkins University Bloomberg School of Public Health. He is also program director of the Industrial Hygiene Training Program and director of the Center for Childhood Asthma in the Urban Environment. His main research interest is in exposure assessment, including pollutant-source characterization; exposure measurement and interpretation; development and use of biomarkers of exposure, dose, and effect; and evaluating relationships between sources, ex- posure, doses, and disease. Dr. Breysse codirected a medical screening program for former Department of Energy workers at the Los Alamos National Labora- tory and serves on the laboratory’s Beryllium Health and Safety Committee. He is a former chair of the American Conference of Governmental Industrial Hy- 160 

Appendix A 161 gienists Worldwide. Dr. Breysse received his MHS in occupational safety and health and his PhD in environmental health engineering from the Johns Hopkins University. Scott W. Burchiel is a professor of pharmacology and toxicology in the College of Pharmacy of the University of New Mexico Health Sciences Center. He is associate dean for research at the college, director of the New Mexico Center for Environmental Health Sciences, and a member of the University of New Mexico Cancer Research and Treatment Center. His research interests are in immu- notoxicology, cancer research, pharmacogenomics, and biotechnology. His labo- ratory examines the effects of drugs and environmental agents on signaling pathways that control lymphocyte activation and apoptosis, proto-oncogene ac- tivation, and mechanisms of signaling in human mammary epithelial cells. Dr. Burchiel was a member of the National Research Council Committee on Assess- ing Human Health Risks of Trichloroethylene. He received his PhD in pharma- cology from the University of California, San Francisco. Lung Chi Chen is an associate professor in the Department of Environmental Medicine of the New York University (NYU) School of Medicine. He is also director of the Inhalation Facility for the National Institute of Environmental Health Sciences Center of Excellence. His research interests are in inhalation toxicology and exposure-response relationships. His recent research has focused on nanoparticle toxicity and functional use, the role of health disparity in air- pollution-induced cardiopulmonary diseases, and gene-environment interactions in environmentally induced diseases. Dr. Chen is vice president-elect of the In- halation Specialty Section of the Society of Toxicology. He received his MS and PhD in environmental health science from NYU. David Díaz-Sánchez is chief of the Clinical Research Branch of the U.S. Envi- ronmental Protection Agency (EPA). Before joining EPA in 2007, he was an associate professor in the Department of Medicine of the University of Califor- nia, Los Angeles. His research interests are in the use of human and animal models to understand the ability of environmental agents to affect immune re- sponses, particularly agents that modulate allergic and asthmatic responses. His recent work has focused on how diesel-exhaust particles exacerbate allergy and asthma, the role of phase II enzymes in conferring susceptibility to pollutants, and the role of oxidative stress in susceptibility to particulate matter and in the potency of particles in promoting airway inflammation. Dr. Díaz-Sánchez is a member of the National Ambient Air Monitoring Strategy Subcommittee of EPA’s Clean Air Science Advisory Committee. He received his PhD from Guy’s Hospital in London. David G. Hoel is Distinguished University Professor in the Department of Bio- statistics, Bioinformatics, and Epidemiology of the Medical University of South Carolina. He also holds an appointment as clinical professor in the Department 

162 Managing Health Effects of Beryllium Exposure of Radiology of the University of South Carolina School of Medicine. His re- search interests are in environmental causes of cancer, risk-assessment models, and epidemiology. Dr. Hoel was elected to the Institute of Medicine in 1988 and was named a national associate of the National Academies in 2001. He received his PhD in statistics from the University of North Carolina at Chapel Hill. Loren D. Koller is an independent consultant and former professor and dean of the College of Veterinary Medicine of Oregon State University. His expertise is in pathology, toxicology, immunotoxicology, carcinogenesis, and risk assess- ment. He is a former member of the National Research Council Committee on Toxicology and of several of its subcommittees, including the Subcommittee on Immunotoxicity and the Subcommittee on Zinc Cadmium Sulfide. He serves on the Committee to Review Chemical Agent Secondary Waste Disposal and Regu- latory Requirements. He received his DVM from Washington State University and his PhD in pathology from the University of Wisconsin. David Kriebel is a professor of epidemiology in the Department of Work Envi- ronment of the University of Massachusetts Lowell and codirector of the Lowell Center for Sustainable Production. His research interests are in the epidemiology of cancer, nonmalignant respiratory disease, and workplace injury. He has con- ducted research on human exposure to asbestos, beryllium, formaldehyde, metal-working fluids, and other environmental and occupational substances. Dr. Kriebel also conducts research on epidemiologic methods aimed particularly at improving the use of quantitative exposure data in epidemiology through bio- logically based dosimetric models. With Harvey Checkoway and Neil Pearce, he is a coauthor of the leading textbook of occupational epidemiology, Research Methods in Occupational Epidemiology. He served on two Institute of Medicine committees that evaluated the health effects of exposure to herbicides in Viet- nam veterans. He received his ScM in physiology and ScD in epidemiology and occupational health from the Harvard School of Public Health. Michael J. McCabe, Jr. is an associate professor in the Department of Envi- ronmental Medicine of the University of Rochester School of Medicine and Dentistry. He is also director of the Immunomodulators and Immunopathogene- sis Program at the university’s Environmental Health Sciences Center. His re- search interests are in the mechanisms of immunomodulation by metals. The central theme of his research is the cellular and biochemical-molecular mecha- nisms that control lymphocyte activation and function. His work focuses on lymphocyte signaling pathways as targets for toxic metals that lead to immuno- suppression or to autoimmune disease. Dr. McCabe is a past president of the Metals Specialty Section of the Society of Toxicology and was a councilor of the Immunotoxicology Specialty Section. He received his MS and PhD in mi- crobiology and immunology from Albany Medical College. 

Appendix A 163 Carrie A. Redlich is a professor of medicine at the Yale University School of Medicine in pulmonary and critical-care medicine and occupational and envi- ronmental medicine and is associate director of the Occupational and Environ- mental Medicine Program. She is also a staff physician at Yale-New Haven Hospital and West Haven Veterans Administration Hospital. Her research inter- ests are in occupational and environmental lung diseases with a focus on the pathogenesis, diagnosis, and prevention of asthma due to isocyanate exposure. Dr. Redlich was a member of the Institute of Medicine Committee on Gulf War and Health: Review of the Literature on Pesticides and Solvents. She received her MD from the Yale University School of Medicine and her MPH in environ- mental health from the Yale University School of Public Health. Rosalind A. Schoof is a consultant in toxicology and risk assessment with Inte- gral Consulting, Inc. She is a board-certified toxicologist with more than 25 years of experience in conducting evaluations of chemical toxicity, health risk assessments for cancer and noncancer end points, and multimedia assessments of exposure to chemicals at diverse mining and mineral-processing sites, manu- facturing sites, landfills, incinerators, and other sources of exposure. Dr. Schoof's research interests include the bioavailability of arsenic and metals in soils and dietary exposure to arsenic and metals. She has served on numerous peer-review panels for U.S. agencies and Canadian ministries and has been a member of several National Research Council committees, including the Sub- committee on Toxicological Risks to Deployed Military Personnel. Dr. Schoof received her PhD in toxicology from the University of Cincinnati. Nancy L. Sprince is a professor in the Department of Occupational and Envi- ronmental Health of the University of Iowa and director of the Heartland Center for Occupational Health and Safety, an education and research center funded by the National Institute for Occupational Safety and Health. Her research interests are in the epidemiology of occupational lung disorders in workers exposed to pulmonary toxins and prevention of occupational and agricultural injuries. From 1978 to 1990, Dr. Sprince was director of the Beryllium Case Registry at Mas- sachusetts General Hospital. She served on the Institute of Medicine Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides. She received her MD from the Boston University School of Medicine and her MPH in occupational and environmental medicine from the Harvard School of Public Health. Susan M. Tarlo is a professor in the Department of Medicine and in the De- partment of Public Health Sciences of the University of Toronto. She is also a respiratory physician at the University Health Network, Toronto Western Hospi- tal, and at the Gage Occupational and Environmental Health Unit of St. Mi- chael’s Hospital in Toronto. Her research interests are in occupational and envi- ronmental lung diseases and allergic responses, especially occupational asthma. Dr. Tarlo received her MB BS (MD equivalent) from London University. 

164 Managing Health Effects of Beryllium Exposure Laura S. Welch is medical director of CPWR—The Center for Construction Research and Training, a research institute devoted to improving health and safety in the construction industry. Her research interests are in asbestos-related diseases, other occupational lung diseases, and musculoskeletal disorders. She is also a lecturer in environmental and occupational health at the George Washing- ton University School of Public Health and Health Services. She has held fac- ulty positions at the university’s medical school and at the Yale University School of Medicine. Dr. Welch received her MD from the State University of New York at Stony Brook and is board-certified in internal medicine and in oc- cupational medicine. She was a member of the Institute of Medicine Committee on Gulf War and Health: Review of the Literature on Pesticides and Solvents.